Literature DB >> 31219194

Encephalitis induced by immune checkpoint inhibitors in metastatic melanoma: a monocentric retrospective study.

S Galmiche1, C Lheure1,2, N Kramkimel1, N Franck1, F Boitier1, N Dupin1,2, G Turc3, D Psimaras4,5, S Aractingi1,2, S Guégan1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31219194     DOI: 10.1111/jdv.15756

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  6 in total

Review 1.  Neurologic complications of immune checkpoint inhibitors.

Authors:  Alexandra M Haugh; John C Probasco; Douglas B Johnson
Journal:  Expert Opin Drug Saf       Date:  2020-03-11       Impact factor: 4.250

2.  Transient altered mental status and leptomeningeal enhancement associated with pembrolizumab: a case report.

Authors:  Keng Lam; Sameer K Kulkarni; Manya Khrlobyan; Pamela K Cheng; Caroline L Fong
Journal:  Neurol Sci       Date:  2021-07-19       Impact factor: 3.307

Review 3.  Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review.

Authors:  Simon Nannini; Larysa Koshenkova; Seyyid Baloglu; Dominique Chaussemy; Georges Noël; Roland Schott
Journal:  J Neurooncol       Date:  2022-04-13       Impact factor: 4.506

4.  Immune checkpoint inhibitors-related encephalitis in melanoma and non-melanoma cancer patients: a single center experience.

Authors:  A Taliansky; O Furman; M Gadot; D Urban; J Bar; R Shapira-Frumer; B Kaufman; N Asher; R Leibowitz-Amit; A Itay
Journal:  Support Care Cancer       Date:  2021-06-12       Impact factor: 3.603

5.  A Family with a Novel CTLA4 Haploinsufficiency Mutation and Neurological Symptoms.

Authors:  Alexandros Grammatikos; Sarah Johnston; Claire M Rice; Mark Gompels
Journal:  J Clin Immunol       Date:  2021-05-06       Impact factor: 8.317

Review 6.  Immune Checkpoint Inhibitors and Neurotoxicity.

Authors:  Zhiyi Zhao; Chunlin Zhang; Lian Zhou; Pan Dong; Lei Shi
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.